[Anal cancer in HIV patients]

Laurent Quéro; Xavier Duval; Laurent Abramowitz

doi:10.1684/bdc.2014.2035

[Anal cancer in HIV patients]

Bull Cancer. 2014 Nov;101(11):1034-9. doi: 10.1684/bdc.2014.2035.

[Article in French]

Authors

Laurent Quéro¹, Xavier Duval², Laurent Abramowitz³

Affiliations

¹ AP-HP, Hôpital Saint-Louis, Service de cancérologie-radiothérapie, 1, avenue Claude-Vellefaux, 75010 Paris, France.
² AP-HP, Hôpital Bichat, Service des maladies infectieuses et tropicales, 75018 Paris, France.
³ AP-HP, Hôpital Bichat, Proctologie médico-chirurgicale, Service de gastro-entérologie, 75018 Paris, France.

PMID: 25418596
DOI: 10.1684/bdc.2014.2035

Abstract

Despite effective highly active antiretroviral treatment, anal cancer incidence has recently strongly increased in HIV-infected population. Treatment strategy in HIV-infected patients does not differ from general population. HIV-infected patients treated by chemo-radiotherapy are exposed to high-grade toxicities and should be closely monitored to deliver the optimal treatment. Close collaboration between oncologist and infectiologist is highly recommended to adjust antiretroviral therapy if necessary.

Keywords: HIV; anal; cancer; review.

Publication types

English Abstract
Review

MeSH terms

Adult
Anti-HIV Agents / therapeutic use
Antineoplastic Agents / therapeutic use
Anus Neoplasms / epidemiology
Anus Neoplasms / etiology*
Carcinoma, Squamous Cell / epidemiology
Carcinoma, Squamous Cell / etiology*
Carcinoma, Squamous Cell / therapy*
Carcinoma, Squamous Cell / virology
Chemoradiotherapy / methods
Combined Modality Therapy
Drug Interactions
HIV Infections / complications*
HIV Infections / drug therapy
Homosexuality, Male / statistics & numerical data
Humans
Incidence
Male
Middle Aged
Radiation Tolerance
Treatment Outcome

Substances

Anti-HIV Agents
Antineoplastic Agents